Sterol O-acyltransferase 1 (SOAT1, ACAT) is a novel target of steroidogenic factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 4, 2011, Pages

  Ferraz De Souza, Bruno ^a   Hudson Davies, Rebecca E ^a   Lin, Lin ^a   Parnaik, Rahul ^a   Hubank, Mike ^b   Dattani, Mehul T ^a   Achermann, John C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE; STEROIDOGENIC FACTOR 1; STEROL O ACYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; ADRENAL GLAND; ADRENAL INSUFFICIENCY; ARTICLE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYP11A GENE; FETUS; FETUS DEVELOPMENT; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PATHOLOGY; MTSS1 GENE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PEG3 GENE; PRIORITY JOURNAL; SOAT1 GENE; STAR GENE; STEROIDOGENESIS; VSNL1 GENE; ZIM2 GENE;

ADRENAL GLANDS; CELLS, CULTURED; CHOLESTEROL; CLUSTER ANALYSIS; EMBRYO, MAMMALIAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; RNA, SMALL INTERFERING; STEROIDOGENIC FACTOR 1; STEROIDS; STEROL O-ACYLTRANSFERASE; STRESS, PHYSIOLOGICAL;

EID: 79953837350     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2021     Document Type: Article

References (18)

1. Parker KL, Schimmer BP 1997 Steroidogenic factor 1: A key determinant of endocrine development and function. Endocr Rev 18: 361-377 (Pubitemid 27246881)
2. Schimmer BP, WhitePC2010 Minireview: Steroidogenic factor 1: Its roles in differentiation, development, and disease. Mol Endocrinol 24:1322-1337
3. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL 1999 A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126 (Pubitemid 29264799)
4. Ito M, Achermann JC, Jameson JL 2000 A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J Biol Chem 275:31708-31714
5. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408 (Pubitemid 34164012)
6. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T 2005 MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942 (Pubitemid 40916416)
7. Ferraz-de-Souza B, Martin F, Mallet D, Hudson-Davies RE, Cogram P, Lin L, Gerrelli D, Beuschlein F, Morel Y, Huebner A, Achermann JC 2009 CBP/p300-interacting transactivator, with Glu/Asprich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. J Clin Endocrinol Metab 94:678-683
8. Chang TY, Li BL, Chang CC, Urano Y 2009 Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab 297: E1-E9
9. Kraemer FB 2007 Adrenal cholesterol utilization. Mol Cell Endocrinol 265-266:42-45
10. Lin L,GuWX,Ozisik G, To WS,OwenCJ, Jameson JL, Achermann JC 2006 Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: Ten years' experience. J Clin Endocrinol Metab 91:3048-3054 (Pubitemid 44271754)
11. Bose HS, Sugawara T, Strauss JF 3rd, Miller WL 1996 The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 335:1870-1878 (Pubitemid 26419194)
12. Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL 2008 Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 93:696-702 (Pubitemid 351398541)
13. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH 1995 Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 270:5772-5778
14. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese JrRV1996 Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci USA 93:14041-14046. (Pubitemid 26424243)
15. Meiner VL, Welch CL, Cases S, Myers HM, Sande E, Lusis AJ, Farese Jr RV 1998 Adrenocortical lipid depletion gene (ald) in AKR mice is associated with an acyl-CoA:cholesterol acyltransferase (ACAT) mutation. J Biol Chem 273:1064-1069. (Pubitemid 28049205)
16. Gwynne JT, Strauss JF 3rd 1982 The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 3:299-329.
17. Lee RG, Willingham MC, Davis MA, Skinner KA, Rudel LL 2000 Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res 41:1991-2001 (Pubitemid 32038994)
18. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM 2006 Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354:1253-1263